Agency Information Collection Activities: Coronavirus 2019 (COVID-19) Data Report, OMB No. 0906-xxxx-Emergency, 32041-32042 [2020-11586]

Download as PDF Federal Register / Vol. 85, No. 103 / Thursday, May 28, 2020 / Notices INFORMATION section for electronic access to the draft guidance document. FOR FURTHER INFORMATION CONTACT: Ryan Newkirk, Center for Food Safety and Applied Nutrition (HFS–005), Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, 240–402– 3712, ryan.newkirk@fda.hhs.gov. SUPPLEMENTARY INFORMATION: In the Federal Register of February 14, 2020 (85 FR 8599), we published a notice announcing the availability of a supplemental draft guidance for industry entitled ‘‘Mitigation Strategies to Protect Food Against Intentional Adulteration: Draft Guidance for Industry.’’ This multichapter supplemental draft guidance for industry is intended to help food facilities required to comply, develop, and implement some of the components of a food defense plan, and meet other requirements under 21 CFR part 121. The Agency has received a request for an extension of the comment period for 120 days. The request conveyed concern that the current comment period does not allow sufficient time to develop a comprehensive response. FDA has considered the request and is extending the comment period for the notice of availability for 60 days, until August 14, 2020. The Agency believes that a 60-day extension allows adequate time for interested persons to submit comments. Dated: May 21, 2020. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2020–11455 Filed 5–27–20; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Agency Information Collection Activities: Coronavirus 2019 (COVID– 19) Data Report, OMB No. 0906-xxxx— Emergency Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: In compliance with of the Paperwork Reduction Act of 1995, HRSA has submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. OMB will accept comments from the public during the review and approval period. OMB may act on HRSA’s ICR only after the 10-day jbell on DSKJLSW7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 16:32 May 27, 2020 Jkt 250001 comment period for this notice has closed. DATES: Comments on this ICR should be received no later than June 8, 2020. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 10 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by using the search function. FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance requests submitted to OMB for review, email Lisa Wright-Solomon, the HRSA Information Collection Clearance Officer at paperwork@hrsa.gov or call (301) 443– 1984. SUPPLEMENTARY INFORMATION: Information Collection Request Title: Coronavirus 2019 (COVID–19) Data Report, OMB No. 0906-xxxx ¥ Emergency Abstract: HRSA’s Ryan White HIV/ AIDS Program (RWHAP) funds and coordinates with cities, states, and local clinics/community-based organizations to deliver efficient and effective HIV care, treatment, and support to low income people with HIV. Nearly twothirds of clients (patients) live at or below 100 percent of the federal poverty level and approximately three-quarters of RWHAP clients are racial/ethnic minorities. Since 1990, the RWHAP has developed a comprehensive system of safety net providers who deliver high quality direct health care and support services to over half a million people with HIV—more than 50 percent of all people with diagnosed HIV in the United States. FY 2020 Coronavirus Aid, Relief, and Economic Security Act On March 27, 2020, the President signed into law the Coronavirus Aid, Relief, and Economic Security Act (CARES Act). The CARES Act appropriated $90 million to HRSA’s RWHAP to prevent, prepare for, and respond to coronavirus disease 2019 (COVID–19). This funding supports 581 RWHAP recipients across the country, including city/county health departments, state health departments, health clinics, community-based organizations, and AIDS Education and Training Centers in their efforts to help prevent or minimize the impact of COVID–19 on RWHAP clients. The award provides RWHAP recipients the flexibility to meet evolving COVID–19 needs in their respective communities, including extending operational hours, increasing staffing hours, purchasing additional equipment, enhancing PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 32041 workforce training and capacity development, and providing critical services to people with HIV during this pandemic, such as home-delivered meals, emergency housing, and transportation. HRSA’s HIV/AIDS Bureau identified a new data collection need to support HRSA’s requirement to monitor and report quarterly to the Secretary of HHS the COVID–19 activities conducted with the CARES Act funding. HRSA is proposing to create a new COVID–19 Data Report (CDR) module that will provide monthly reporting on the types of services provided and number of people served for the treatment or prevention of COVID–19 among RWHAP clients (and immediate household members in limited circumstances). This module will be required for all providers (regardless of whether they are recipients or subrecipients) who receive CARES Act RWHAP funding. Need and Proposed Use of the Information: HRSA proposes that service providers who receive CARES Act RWHAP funding report aggregate information on the number of clients and immediate household members tested for COVID–19, the number of clients newly diagnosed (or presumed positive) with COVID–19, the cumulative number of clients with COVID–19, the number of clients who received services in each RWHAP service category (identified in Policy Clarification Notice 16–02 RWHAP Services: Eligible Individuals and Allowable Uses of Funds), and the types of services provided using telehealth technology in the CDR. The information obtained in this module will assist HRSA in understanding how CARES Act RWHAP funding is being used to support RWHAP clients and immediate household members and ensure that HRSA is compliant with federal reporting requirements. Likely Respondents: All RWHAP providers (regardless of whether they are recipients or subrecipients) who receive CARES Act RWHAP funding. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install, and utilize technology and systems for the purpose of collecting, validating, and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review E:\FR\FM\28MYN1.SGM 28MYN1 32042 Federal Register / Vol. 85, No. 103 / Thursday, May 28, 2020 / Notices the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this ICR are summarized in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Form name COVID–19 Data Report (CVD) ........................................ Maria G. Button, Director, Executive Secretariat. [FR Doc. 2020–11586 Filed 5–27–20; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings jbell on DSKJLSW7X2PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Non-HIV Anti-viral Therapeutics. Date: June 23–24, 2020. Time: 9:00 a.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Bidyottam Mittra, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, Bethesda, MD 20894, (301) 435–4057, bidyottam.mittra@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; The BloodBrain Barrier, Neurovascular System and CNS Therapeutics. Date: June 23, 2020. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). VerDate Sep<11>2014 16:32 May 27, 2020 Jkt 250001 2045 2045 Number of responses per respondent 12 ........................ Contact Person: Linda MacArthur, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4187, Bethesda, MD 20892, 301–537–9986, macarthurlh@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Dermatology, Rheumatology and Inflammation. Date: June 23, 2020. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Rajiv Kumar, Ph.D., Chief, MOSS IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4216, MSC 7802 Bethesda, MD 20892, 301–435–1212, kumarra@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Digestive Sciences. Date: June 24, 2020. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Ganesan Ramesh, Ph.D., Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2182 MSC 7818, Bethesda, MD 20892, 301–827–5467, ganesan.ramesh@nih.gov. Name of Committee: Genes, Genomes, and Genetics Integrated Review Group; Therapeutic Approaches to Genetic Diseases Study Section. Date: June 24–25, 2020. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Methode Bacanamwo, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2200, Bethesda, MD 20892, 301–827–7088, methode.bacanamwo@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 Average burden per response (in hours) Total responses 24,540 24,540 Total burden hours 2 ............................ 49,080 49,080 Dated: May 21, 2020. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–11381 Filed 5–27–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Allergy, Immunology, and Transplantation Research Committee Allergy, Immunology, and Transplantation Research Committee (AITC) October Council. Date: June 25–26, 2020. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G31B, Rockville, MD 20892, (Telephone Conference Call). Contact Person: James T. Snyder, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health, National Institute of Allergy and Infectious Diseases, 5601 Fishers Lane, Room 3G31B, Bethesda, MD 20892–9834, (240) 669–5060, james.snyder@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, E:\FR\FM\28MYN1.SGM 28MYN1

Agencies

[Federal Register Volume 85, Number 103 (Thursday, May 28, 2020)]
[Notices]
[Pages 32041-32042]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-11586]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Agency Information Collection Activities: Coronavirus 2019 
(COVID-19) Data Report, OMB No. 0906-xxxx--Emergency

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with of the Paperwork Reduction Act of 1995, 
HRSA has submitted an Information Collection Request (ICR) to the 
Office of Management and Budget (OMB) for review and approval. OMB will 
accept comments from the public during the review and approval period. 
OMB may act on HRSA's ICR only after the 10-day comment period for this 
notice has closed.

DATES: Comments on this ICR should be received no later than June 8, 
2020.

ADDRESSES: Written comments and recommendations for the proposed 
information collection should be sent within 10 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by using the search function.

FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance 
requests submitted to OMB for review, email Lisa Wright-Solomon, the 
HRSA Information Collection Clearance Officer at [email protected] or 
call (301) 443-1984.

SUPPLEMENTARY INFORMATION:
    Information Collection Request Title: Coronavirus 2019 (COVID-19) 
Data Report, OMB No. 0906-xxxx - Emergency
    Abstract: HRSA's Ryan White HIV/AIDS Program (RWHAP) funds and 
coordinates with cities, states, and local clinics/community-based 
organizations to deliver efficient and effective HIV care, treatment, 
and support to low income people with HIV. Nearly two-thirds of clients 
(patients) live at or below 100 percent of the federal poverty level 
and approximately three-quarters of RWHAP clients are racial/ethnic 
minorities. Since 1990, the RWHAP has developed a comprehensive system 
of safety net providers who deliver high quality direct health care and 
support services to over half a million people with HIV--more than 50 
percent of all people with diagnosed HIV in the United States.

FY 2020 Coronavirus Aid, Relief, and Economic Security Act

    On March 27, 2020, the President signed into law the Coronavirus 
Aid, Relief, and Economic Security Act (CARES Act). The CARES Act 
appropriated $90 million to HRSA's RWHAP to prevent, prepare for, and 
respond to coronavirus disease 2019 (COVID-19). This funding supports 
581 RWHAP recipients across the country, including city/county health 
departments, state health departments, health clinics, community-based 
organizations, and AIDS Education and Training Centers in their efforts 
to help prevent or minimize the impact of COVID-19 on RWHAP clients. 
The award provides RWHAP recipients the flexibility to meet evolving 
COVID-19 needs in their respective communities, including extending 
operational hours, increasing staffing hours, purchasing additional 
equipment, enhancing workforce training and capacity development, and 
providing critical services to people with HIV during this pandemic, 
such as home-delivered meals, emergency housing, and transportation.
    HRSA's HIV/AIDS Bureau identified a new data collection need to 
support HRSA's requirement to monitor and report quarterly to the 
Secretary of HHS the COVID-19 activities conducted with the CARES Act 
funding. HRSA is proposing to create a new COVID-19 Data Report (CDR) 
module that will provide monthly reporting on the types of services 
provided and number of people served for the treatment or prevention of 
COVID-19 among RWHAP clients (and immediate household members in 
limited circumstances). This module will be required for all providers 
(regardless of whether they are recipients or subrecipients) who 
receive CARES Act RWHAP funding.
    Need and Proposed Use of the Information: HRSA proposes that 
service providers who receive CARES Act RWHAP funding report aggregate 
information on the number of clients and immediate household members 
tested for COVID-19, the number of clients newly diagnosed (or presumed 
positive) with COVID-19, the cumulative number of clients with COVID-
19, the number of clients who received services in each RWHAP service 
category (identified in Policy Clarification Notice 16-02 RWHAP 
Services: Eligible Individuals and Allowable Uses of Funds), and the 
types of services provided using telehealth technology in the CDR. The 
information obtained in this module will assist HRSA in understanding 
how CARES Act RWHAP funding is being used to support RWHAP clients and 
immediate household members and ensure that HRSA is compliant with 
federal reporting requirements.
    Likely Respondents: All RWHAP providers (regardless of whether they 
are recipients or subrecipients) who receive CARES Act RWHAP funding.
    Burden Statement: Burden in this context means the time expended by 
persons to generate, maintain, retain, disclose or provide the 
information requested. This includes the time needed to review 
instructions; to develop, acquire, install, and utilize technology and 
systems for the purpose of collecting, validating, and verifying 
information, processing and maintaining information, and disclosing and 
providing information; to train personnel and to be able to respond to 
a collection of information; to search data sources; to complete and 
review

[[Page 32042]]

the collection of information; and to transmit or otherwise disclose 
the information. The total annual burden hours estimated for this ICR 
are summarized in the table below.

                                     Total Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                   Number of                     Average burden
           Form name               Number of     responses per       Total        per response     Total burden
                                  respondents     respondent       responses       (in hours)          hours
----------------------------------------------------------------------------------------------------------------
COVID-19 Data Report (CVD)....            2045              12          24,540                 2          49,080
                                          2045  ..............          24,540  ................          49,080
----------------------------------------------------------------------------------------------------------------


Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020-11586 Filed 5-27-20; 8:45 am]
BILLING CODE 4165-15-P